Tandem Diabetes Care, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Tandem Diabetes Care, Inc. (TNDM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $940.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-02-19
- Tandem Diabetes Care, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $940.00K, a 62.14% decline from fiscal 2024.
- Tandem Diabetes Care, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $2.48M, a 77.36% increase from fiscal 2023.
- Tandem Diabetes Care, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $1.40M, a 89.61% decline from fiscal 2022.
- Tandem Diabetes Care, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $13.47M, a 84.36% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|
| 2025-12-31 | $940.00K 10-K · filed 2026-02-19 |
| 2024-12-31 | $2.48M 10-K · filed 2026-02-19 |
| 2023-12-31 | $1.40M 10-K · filed 2026-02-19 |
| 2022-12-31 | $13.47M 10-K · filed 2025-02-26 |
| 2021-12-31 | $86.15M 10-K · filed 2024-02-21 |
| 2020-12-31 | $161.69M 10-K · filed 2023-02-22 |
| 2019-12-31 | $71.81M 10-K · filed 2021-02-24 |
| 2018-12-31 | $3.95M 10-K · filed 2020-02-24 |
| 2017-12-31 | $338.00K 10-K · filed 2019-02-26 |
| 2016-12-31 | $1.05M 10-K · filed 2018-03-01 |
| 2015-12-31 | $2.54M 10-K · filed 2017-03-08 |
| 2014-12-31 | $1.96M 10-K · filed 2016-02-24 |
| 2013-12-31 | $118.00K 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |